Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-41105

ROTH CH ACQUISITION V CO.

(Exact name of registrant as specified in its charter)

Delaware		86-1229207
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

888 San Clemente Drive, Suite 400

Newport Beach, CA 92660

(Address of principal executive offices) (Zip Code)

(949) 720-5700

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	ROCL	The Nasdaq Stock Market LLC
Warrants	ROCLW	The Nasdaq Stock Market LLC
Units	ROCLU	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 20, 2023, there were 5,847,012 shares of common stock, par value $0.0001 per share, issued and outstanding.

ROTH CH ACQUISITION V CO.

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023

TABLE OF CONTENTS

		Page
Part I. Financial Information
Item 1. Financial Statements		1
Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 (Unaudited)		1
Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022(Unaudited)		2
Condensed Statements of Changes in Stockholders’ (Deficit) Equity for the Three and Nine Months Ended September 30, 2023 and 2022 (Unaudited)		3
Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022 (Unaudited)		4
Notes to Condensed Financial Statements (Unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		20
Item 3. Quantitative and Qualitative Disclosures About Market Risk		25
Item 4. Controls and Procedures		25
Part II. Other Information
Item 1. Legal Proceedings		26
Item 1A. Risk Factors		26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		26
Item 3. Defaults Upon Senior Securities		26
Item 4. Mine Safety Disclosures		26
Item 5. Other Information		26
Item 6. Exhibits		27
Signatures		28

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

ROTH CH ACQUISITION V CO.

CONDENSED BALANCE SHEETS

(UNAUDITED)


	September 30,			December 31,
	2023			2022
ASSETS
Current assets
Cash	$	112,941		$	687,471
Prepaid expenses		76,766			150,250
Cash and marketable securities held in Trust Account		26,711,906			118,377,460
Total Current Assets		26,901,613			119,215,181

Total Assets	$	26,901,613		$	119,215,181

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities
Accrued expenses	$	733,415		$	224,719
Due to Non-redeeming Stockholders		151,189			-
Promissory note – related party		250,000			-
Excise taxes payable		930,108			-
Income taxes payable		51,673			421,211
Total Current Liabilities		2,116,385			645,930

Commitments and Contingencies

Common stock subject to possible redemption, $0.0001 par value; 2,510,512 and 11,500,000 shares at $10.59 per share and $10.24 per share redemption value as of September 30, 2023 and December 31, 2022, respectively		26,591,561			117,809,374

Stockholders’ (Deficit) Equity
Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,336,500 shares issued and outstanding (excluding 2,510,512 and 11,500,000 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively		334			334
Additional paid-in capital		-			205,072
Accumulated (deficit) earnings		(1,806,667	)		554,471
Total Stockholders’ (Deficit) Equity		(1,806,333	)		759,877

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	26,901,613		$	119,215,181

The accompanying notes are an integral part of the unaudited condensed financial statements.

ROTH CH ACQUISITION V CO.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)


	For the Three Months Ended						For the Nine Months Ended
	September 30,						September 30,
	2023			2022			2023			2022
General and administrative expenses	$	908,357		$	122,934		$	1,293,488		$	416,559
Loss from operations		(908,357	)		(122,934	)		(1,293,488	)		(416,559	)

Other income (expense)
Interest earned on marketable securities held in Trust Account		343,491			526,853			2,641,366			697,289
Change in fair value of due to non-redeeming stockholders		8,811			-			(471,189	)		-
Total other income, net		352,302			526,853			2,170,177			697,289

(Loss) Income before provision for income taxes		(556,055	)		403,919			876,689			280,730
Provision for income taxes		(90,037	)		(99,588	)		(719,832	)		(117,471	)
Net (loss) income	$	(646,092	)	$	304,331		$	156,857		$	163,259

Basic and diluted weighted average shares outstanding, common stock subject to possible redemption		2,510,512			11,500,000			7,482,720			11,500,000
Basic and diluted net (loss) income per common share, common stock subject to possible redemption	$	(0.07	)	$	0.03		$	0.13		$	0.02

Basic and diluted weighted average shares outstanding, non-redeemable common stock		3,336,500			3,336,500			3,336,500			3,336,500
Basic and diluted net (loss) income per share, non-redeemable common stock	$	(0.14	)	$	(0.00	)	$	(0.24	)	$	(0.02	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

ROTH CH ACQUISITION V CO.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

(UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023


	Common Stock				Additional Paid-in				Accumulated			Total Stockholders’ (Deficit)
	Shares		Amount		Capital				Deficit			Equity
Balance — January 1, 2023		3,336,500	$	334	$	205,072		-	$	554,471		$	759,877

Accretion of carrying value to redemption value		-		-		(205,072	)			(669,501	)		(874,573	)

Net income		-		-		-		-		708,556			708,556

Balance — March 31, 2023		3,336,500		334		-		-		593,526			593,860

Accretion of carrying value to redemption value		-		-		-				(729,454	)		(729,454	)

Excise taxes on stock redemption										(930,108	)		(930,108	)

Net income		-		-		-		-		94,393			94,393

Balance — June 30, 2023		3,336,500		334		-		-		(971,643	)		(971,309	)

Accretion of carrying value to redemption value		-		-		-				(188,932	)		(188,932	)

Net loss		-		-		-		-		(646,092	)		(646,092	)

Balance — September 30, 2023		3,336,500	$	334	$	-		-	$	(1,806,667	)	$	(1,806,333	)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

	Common Stock				Additional Paid-in			Stock Subscription Receivable from		Accumulated			Total Stockholders’
	Shares		Amount		Capital			Stockholder		Deficit			Equity
Balance — January 1, 2022		3,336,500	$	334	$	1,289,446		$	-	$	(167,644	)	$	1,122,136

Net loss		-		-		-			-		(151,738	)		(151,738	)

Balance — March 31, 2022		3,336,500		334		1,289,446			-		(319,382	)		970,398

Accretion of carrying value to redemption value		-		-		(72,983	)		-		-			(72,983	)

Net income		-		-		-			-		10,666			10,666

Balance — June 30, 2022		3,336,500		334		1,216,463			-		(308,716	)		908,081

Accretion of carrying value to redemption value		-		-		(369,382	)		-		-			(369,382	)

Net income		-		-		-			-		304,331			304,331

Balance — September 30, 2022		3,336,500	$	334	$	847,081		$	-	$	(4,385	)	$	843,030

The accompanying notes are an integral part of the unaudited condensed financial statements.

ROTH CH ACQUISITION V CO.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)


	For the Nine Months Ended September 30,
	2023			2022
Cash Flows from Operating Activities:
Net income	$	156,857		$	163,259
Adjustment to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(2,641,366	)		(697,289	)
Change in fair value of due to non-redeeming stockholders		471,189
Changes in operating assets and liabilities:
Prepaid expenses		73,484			130,158
Accrued expenses		508,696			72,077
Income taxes payable		(369,538	)		117,471
Net cash used in operating activities		(1,800,678	)		(214,324	)

Cash Flows from Investing Activities:
Cash withdrawn from Trust Account to pay franchise and income taxes		1,296,148			-
Cash withdrawn from Trust Account in connection with redemption		93,010,772			-
Net cash provided by investing activities		94,306,920			-

Cash Flows from Financing Activities:
Proceeds from promissory note - related party		250,000			-
Payments to non-redeeming stockholders		(320,000	)		-
Redemption of common stock		(93,010,772	)		-
Net cash used in financing activities		(93,080,772	)		-

Net Change in Cash		(574,530	)		(214,324	)
Cash – Beginning of period		687,471			898,895
Cash – End of period	$	112,941		$	684,571

Non-cash financing activities:
Change in value of Class A common stock subject to possible redemption	$	1,792,959		$	442,365
Excise taxes on stock redemption	$	930,108		$	-

Supplemental information
Income taxes paid	$	1,089,370		$	-

The accompanying notes are an integral part of the unaudited condensed financial statements.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Roth CH Acquisition V Co. (the “Company”) was incorporated in Delaware on November 5, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with 1 one or more businesses or entities (the “Business Combination”).

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 related to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and, subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below).

The registration statement for the Company’s Initial Public Offering was declared effective on November 30, 2021. On December 3, 2021, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $115,000,000, which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 461,500 units (the “Private Units”) at a price of $10.00 per Private Unit in a private placement to certain of the Company’s initial stockholders, generating gross proceeds of $4,615,000, which is described in Note 4.

Transaction costs amounted to $1,625,220, consisting of $1,150,000 of underwriting fees, and $475,220 of other offering costs.

Following the closing of the Initial Public Offering on December 3, 2021, an amount of $116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (the “Trust Account”), located in the United States and held in cash items or invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the proceeds from the Trust Account, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Company’s shares prior to the Initial Public Offering (the “Initial Stockholders”) have agreed (a) to vote their Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of how or whether they vote on the proposed transaction or do not vote at all.

The Initial Stockholders have agreed (a) to waive their redemption rights with respect to their Founder Shares, Private Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

The Company will have until December 4, 2023 (unless the Company extends the period of time it has to complete an initial business combination) to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes and liquidation expenses, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

On May 17, 2023, the Company held a special meeting of stockholders (the “Special Meeting”), at which the Company’s stockholders approved an amendment (the “Extension Amendment”) to the Amended and Restated Certificate of Incorporation to give the Company the right to extend the date by which the Company has to consummate a business combination up to six (6) times, each such extension for an additional one (1) month period, from June 3, 2023 to December 4, 2023. In connection with the Special Meeting stockholders exercised their right to redeem 8,989,488 shares of common stock for an aggregate price of approximately $10.36 per share, for an aggregate redemption amount of $93,010,772. After the satisfaction of such redemptions, the balance in the Company’s Trust account on June 2, 2023, was $27,077,077 (including interest not previously released to the Company).

On May 3 and 4, 2023, the Company entered into non-redemption agreements with certain stockholders owning, in the aggregate, 2,000,000 shares of the Company’s common stock (the “Non-redeeming Stockholders”), pursuant to which such stockholders agreed, among other things, not to redeem or exercise any right to redeem such public shares in connection with the Extension Amendment. In consideration of such agreements, certain of our Initial Stockholders agreed to pay the Non-redeeming Stockholders that entered into such agreements $0.04 per share for each one-month extension. On July 20, 2023, the Company entered into amendments to the non-redemption agreements to provide that the Company or certain Initial Stockholders, or their affiliates or designees, will pay such stockholders that entered into the non-redemption agreements $0.04 per share for each one-month extension in connection with such agreements. On May 30, 2023, June 29, 2023, July 31, 2023, August 31, 2023, October 2, 2023 and November 6, 2023, the Company issued payments to the Non-redeeming Stockholders in the aggregate amount of $480,000 in relation to the extension of the Combination Period through December 4, 2023. The payments were presented as finance costs in the accompanying condensed statements of operations. The Company evaluated the classification and accounting of the payments to the Non-redeeming shareholders under ASC 815-40, “Derivatives and Hedging-Contracts in Entity’s Own Equity”. ASC 815-40 states that if an instrument is not considered indexed to a reporting entity’s own stock, it should be classified as an asset or liability and recorded at fair value with changes in fair value recorded in the income statement. The Company determined that as of September 30, 2023, a liability due to non-redeeming stockholders should be recorded at a fair value of $151,189 and is included in the accompanying unaudited condensed balance sheets. The Company recognized $8,811 of income and $471,189 of expense for the fair value of due to non-redeeming shareholders in the accompanying unaudited condensed statement of operations for the three and nine months ended September 30, 2023, respectively. The Company recognized no expense for the fair value of due to non-redeeming shareholders in the accompanying unaudited condensed statement of operations for the three and nine months ended September 30, 2022.

The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the per share value deposited into the Trust Account ($10.15).

In order to protect the amounts held in the Trust Account, the Initial Stockholders have agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.15 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Initial Stockholders will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Initial Stockholders will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

Liquidity and Going Concern

As of September 30, 2023, the Company had $112,941 in its operating bank account and a working capital deficit of $1,926,678.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for performing due diligence on prospective target businesses, paying for travel expenditures, and structuring, negotiating, and consummating the Business Combination.

On July 26, 2023, the Company issued an unsecured promissory note in the aggregate amount of up to $750,000 (the “Note”) to individuals or entities listed on the Note. The Note is non-interest bearing and is payable on the earlier of (i) the date on which the Company consummates an initial business combination or (ii) the date the Company liquidates if a Business Combination is not consummated. The Note will be repaid only from amounts remaining outside of the Company’s Trust Account, if any. The proceeds will be used by the Company to pay various expenses of the Company, including the extension payments, and for general corporate purposes. At September 30, 2023, there was $250,000 outstanding under the Note.

The Company will need to raise additional capital through loans or additional investments from the Initial Stockholders or its officers, directors or their affiliates. The Initial Stockholders and the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. If an initial business combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the date that these financial statements are issued. The Company plans to address this uncertainty through working capital loans and through consummation of our initial business combination. There is no assurance that working capital loans will be available to the Company or that our plans to consummate a business combination will be successful; therefore, there is substantial doubt about our ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Risks and Uncertainties

The Company continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that COVID-19 could have a negative effect on the Company’s search for a target company for a Business Combination, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

In connection with the stockholders’ vote at the Special Meeting, public stockholders exercised their right to redeem 8,989,488 shares of common stock for a total of $93,010,772. Excise tax should be recognized in the period incurred, that is when the repurchase occurs. Any reduction in the tax liability due to a subsequent stock issuance, or an event giving rise to an exception, that occurs within a tax year should be recorded in the period of such stock issuance or event giving rise to an exception. As of September 30, 2023, the Company recorded $930,108 of excise tax liability calculated as 1% of shares redeemed on May 31, 2023.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.

Marketable Securities Held in Trust Account

At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U. S. Treasury securities.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2023 and December 31, 2022, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable common stock resulted in a charge against additional paid-in capital to the extent possible, and when additional paid-in capital is reduced to 0 zero, to retained earnings.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

At September 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected in the balance sheets is reconciled in the following table:


Gross proceeds	$	115,000,000
Less:
Common stock issuance costs		(1,625,220	)
Plus:
Accretion of carrying value to redemption value		3,350,220
Common stock subject to possible redemption, December 31, 2021		116,725,000
Plus:
Accretion of carrying value to redemption value		1,084,374
Common stock subject to possible redemption, December 31, 2022		117,809,374
Less:
Shares Redeemed		(93,010,772	)
Plus:
Accretion of carrying value to redemption value		1,792,959
Common stock subject to possible redemption, September 30, 2023	$	26,591,561

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. The effective tax rate was 16.19% and 24.66% for the three months ended September 30, 2023 and 2022, respectively, (82.11%) and 41.84% for the nine months ended September 30, 2023 and 2022. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, due to the valuation allowance on the deferred tax assets and the change in fair value of due to non-redeeming stockholders.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net (Loss) Income per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two types of common stock – redeemable common stock and non-redeemable common stock. The Company calculates its earnings per share to allocate net (loss) income pro rata to redeemable and non-redeemable common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the (loss) income of the Company. In order to determine the net (loss) income attributable to both the redeemable and non-redeemable common stock, the Company first considered the total (loss) income allocable to both sets of shares. This is calculated using the total net (loss) income less any dividends paid. For the purposes of calculating net (loss) income per share, any remeasurement of the accretion to redemption value of the redeemable common stock subject to redemption and the excise tax calculated on the redemption of shares are considered to be dividends paid to the holders of the redeemable common stock.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

The calculation of diluted (loss) income per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,980,750 shares of common stock in the aggregate. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented.

The following tables reflect the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts):


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2023			2022			2023			2022
Net (loss) income	$	(646,092	)	$	304,331		$	156,857		$	163,259
Accretion of redeemable common stock to redemption amount		(188,932	)		(369,382	)		(1,792,959	)		(442,365	)
Excise taxes on stock redemption		-			-			(930,108	)		-
Net loss including accretion of temporary equity to redemption value and excise taxes on stock redemption	$	(835,024	)	$	(65,051	)	$	(2,566,210	)	$	(279,106	)


	For the Three Months Ended September 30,												For the Nine Months Ended September 30,
	2023						2022						2023						2022
	Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable
	Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock
Basic and diluted net (loss) income per common share
Numerator:
Allocation of net loss including accretion of temporary equity to redemption value	$	(358,531	)	$	(476,493	)	$	(50,422	)	$	(14,629	)	$	(1,774,826	)	$	(791,384	)	$	(216,339	)	$	(62,767	)
Accretion of common stock to redemption value		188,932			-			369,382			-		$	1,792,959			-			442,365			-
Excise taxes on stock redemption		-			-			-			-			930,108			-			-			-
Net (loss) income	$	(169,599	)	$	(476,493	)	$	318,960		$	(14,629	)	$	948,241		$	(791,384	)	$	226,026		$	(62,767	)
Denominator:
Basic and diluted weighted average shares outstanding		2,510,512			3,336,500			11,500,000			3,336,500			7,482,720			3,336,500			11,500,000			3,336,500
Basic and diluted net (loss) income per common share	$	(0.07	)	$	(0.14	)	$	0.03		$	(0.00	)	$	0.13		$	(0.24	)	$	0.02		$	(0.02	)

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.

Warrant Classification

The Company accounts for warrants as either equity-classified instruments or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification(“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Company’s has analyzed the Public Warrants and Private Warrants and determined they are considered to be freestanding instruments and do not exhibit any of the characteristics in ASC 480 and therefore are not classified as liabilities under ASC 480 or ASC 815.

NOTE 3. INITIAL PUBLIC OFFERING

On December 3, 2021, pursuant to the Initial Public Offering, the Company sold 11,500,000 Units, which included a full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one 1 share of common stock and one-half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder thereof to purchase 1 one share of common stock at an exercise price of $11.50 per full share, subject to adjustment (see Note 7).

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, certain of the Initial Stockholders purchased from the Company an aggregate of 461,500 Private Units at a price of $10.00 per Private Unit, for an aggregate purchase price of $4,615,000, in a private placement. Each Private Unit consists of 1 one share of common stock (“Private Share”) and one-half of one redeemable warrant (“Private Warrant”). Each whole Private Warrant entitles the holder thereof to purchase 1 one share of common stock at a price of $11.50 per full share, subject to adjustment (see Note 7). The proceeds from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

In December 2020, certain of the Initial Stockholders purchased an aggregate of 4,312,500 shares of common stock from the Company for an aggregate purchase price of $25,000. In September 2021, certain of the Initial Stockholders sold an aggregate of 1,547,802 shares back to the Company for an aggregate purchase price of $959.14. Of those shares, 1,437,500 shares were cancelled, and the remaining 110,302 shares were purchased by certain of the Initial Stockholders from the Company for an aggregate purchase price of $959.14, resulting in an aggregate of 2,875,000 shares of common stock being held by the Initial Stockholders (the “Founder Shares”). On November 22, 2021, CR Financial Holdings, Inc. sold an aggregate of 56,932 shares to the Company’s independent directors for an aggregate purchase price of $495.05.

The sale of the Founder Shares to certain of the Company’s Initial Stockholders and independent directors, as described above, is within the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The fair value of the 167,234 shares sold to the Company’s Initial Stockholders and independent directors was approximately $788,900, or $4.72 per share. The Founder Shares were effectively sold subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence. Stock-based compensation will be recognized at the date a Business Combination is considered probable in an amount equal to the number of Founder Shares times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of the Founder Shares. As of September 30, 2023, the Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized.

The Initial Stockholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until (1) with respect to 50% of the Founder Shares, the earlier of 6 six months after the completion of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after a Business Combination and (2) with respect to the remaining 50% of the Founder Shares, six months after the completion of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

Working Capital Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the Initial Stockholders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would be repaid upon consummation of a Business Combination, without interest. On July 26, 2023, the Company issued an unsecured promissory note in the aggregate amount of up to $750,000 (the “Note”) to individuals or entities listed on the Note. The Note is non-interest bearing and is payable on the earlier of (i) the date on which the Company consummates an initial business combination or (ii) the date the Company liquidates if a Business Combination is not consummated. The Note will be repaid only from amounts remaining outside of the Company’s Trust Account, if any. The proceeds will be used by the Company to pay various expenses of the Company, including the extension payments, and for general corporate purposes. As of September 30, 2023 and December 31, 2022, there were Working Capital Loans outstanding of $250,000 and $0, respectively.

Underwriting Agreement and Business Combination Marketing Agreement

The Company entered into an underwriting agreement and a business combination marketing agreement with Roth Capital Partners, LLC (“Roth”) and Craig-Hallum Capital Group LLC (“Craig-Hallum”), the underwriters in the Initial Public Offering. The underwriters are related parties of the Company. See Note 6 for a discussion of the business combination marketing agreement.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on November 30, 2021, the holders of the Founder Shares, as well as the holders of the Private Units (and underlying securities), are entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. They can elect to exercise these registration rights (i) at any time commencing three months prior to the date of release from escrow with respect to the Founder Shares or (ii) at any time after the Company consummates a Business Combination with respect to the Private Units (and the underlying securities). In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Notwithstanding the foregoing, they may not exercise demand or piggyback rights after five (5) and seven (7) years, respectively, from the effective date of the Initial Public Offering and may not exercise demand rights on more than one occasion in respect of all registrable securities.

Underwriting Agreement

The underwriters received an underwriting discount of 1.0% of the gross proceeds of the Initial Public Offering, or $1,150,000.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

Business Combination Marketing Agreement

Pursuant to a business combination marketing agreement entered into on November 30, 2021, the Company engaged Roth and Craig-Hallum, the underwriters in the Initial Public Offering, as advisors in connection with its Business Combination to assist in the transaction structuring and negotiation of a definitive purchase agreement with respect to the Business Combination, hold meetings with the stockholders to discuss the Business Combination and the target’s attributes, introduce the Company to potential investors to purchase its securities in connection with the Business Combination, and assist with financial analysis, presentations, press releases and filings related to the Business Combination. The Company will pay Roth and Craig-Hallum a fee for such services upon the consummation of a Business Combination in an amount equal to, in the aggregate, 4.5% of the gross proceeds of the Initial Public Offering (or $5,175,000 in the aggregate). As a result, Roth and Craig-Hallum will not be entitled to such fee unless the Company consummates a Business Combination.

NOTE 7. STOCKHOLDERS’ EQUITY

Common Stock — The Company is authorized to issue 50,000,000 shares of common stock with a par value of $0.0001 per share. On May 31, 2023, in connection with the stockholders’ vote at the Special Meeting, stockholders exercised their right to redeem 8,989,488 shares of common stock. At September 30, 2023 and December 31, 2022, there were 3,336,500 shares of common stock issued and outstanding, excluding 2,510,512 and 11,500,000 shares of common stock subject to possible redemption which are presented as temporary equity, respectively.

Warrants — At September 30, 2023 and December 31, 2022, there were 5,750,000 Public Warrants outstanding and 230,750 Private Warrants outstanding.

The Company will not issue fractional warrants. The Public Warrants will become exercisable 30 days after the completion of a Business Combination. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if the registration statement of which the prospectus for the Company’s Initial Public Offering forms a part is not available and a new registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within 120 days following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. The warrants will expire five 5 years from the closing of a Business Combination.

The Company may redeem the Public Warrants:

	●	in whole and not in part;

	●	at a price of $0.01 per warrant;

	●	at any time after the warrants become exercisable;

	●	upon not less than 30 days’ prior written notice of redemption to each warrant holder;

	●	if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share, for any 20 trading days within a 30-day trading period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

●

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the Market Price.

Except with respect to certain registration rights and transfer restrictions, the Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering.

NOTE 8. FAIR VALUE MEASUREMENTS

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

At September 30, 2023 and December 31, 2022, assets held in the Trust Account were comprised of $26,711,906 and $118,377,460 in mutual funds, respectively. Through September 30, 2023, the Company withdrew $1,328,243 of interest earned on the Trust Account to pay for its tax obligations and $93,010,772 for redemption of shares in connection with the stockholders’ vote at the Special Meeting.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Level 1 instruments include investments in money market funds. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.


		September 30,		December 31,
Description	Level	2023		2022
Assets:
U.S. Mutual Funds Held in Trust Account	1	$	26,711,906	$	118,377,460

Liabilities:
Due to non-redeeming stockholders	3	$	151,189	$	-

Due to Non-redeeming Stockholders

The payments due to the Non-redeeming Stockholders in connection with the non-redemption agreements are accounted for as liabilities in accordance with ASC 815-40 and are presented within due to Non-redeeming Stockholders on the accompanying balance sheets. The liability due to Non-redeeming Stockholders was initially valued based on the terms of the non-redemption agreements in which the Company and certain of our Initial Stockholders agreed to pay the Non-redeeming Stockholders that entered into such agreements $0.04 per share for each one-month extension. The fair value was determined using a probability weighted expected return model that fair values the extension payment.

The following table presents the changes in the fair value of Level 3 liability due to Non-redeeming Stockholders:


Fair value as of December 31, 2022	$	-
Initial value		480,000
Payments to Non-redeeming Stockholders		(320,000	)
Change in fair value of due to Non-redeeming Stockholders		(8,811	)
Fair value as of September 30, 2023	$	151,189

Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no other transfers to/from Levels 1, 2, and 3 during the three-month period ending September 30, 2023.

ROTH CH ACQUISITION V CO.

NOTES TO CONDENSED FINANCIAL STATEMENTS

September 30, 2023

(Unaudited)

NOTE 9. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than stated below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

On October 2, 2023 and November 6, 2023, the Company paid an aggregate of $240,000 to the Non-redeeming Stockholders in connection with the one-month extensions of the Combination Period from October 3, 2023 to December 4, 2023.

On October 2, 2023, October 3, 2023, October 10, 2023, and October 11, 2023, the Company drew additional amounts in the aggregate of $149,859 on the Note.

On October 9, 2023, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company no longer complies with Nasdaq’s continued listing rules on The Nasdaq Global Market due to the Company not having maintained a minimum of 400 total holders for continued listing, as required pursuant to Nasdaq Listing Rule 5450(a)(2). In accordance with the Nasdaq listing rules, the Company has 45 calendar days to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq can grant the Company an extension of up to 180 calendar days from the date of the letter to evidence compliance. The Company plans to submit a compliance plan within the specified period.

On November 8, 2023, the Company filed a preliminary proxy statement in connection with a special meeting of stockholders, at which the Company’s stockholders will consider and vote upon (i) a proposal to allow the Company, without further stockholder approval, to amend (the “Second Extension Amendment”) the Company’s amended and restated certificate of incorporation (the “Charter”), to extend the date by which the Company has to consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period, from December 4, 2023 to December 3, 2024 (i.e., for a period of time ending 36 months after the consummation of the Company’s initial public offering); (ii) a proposal to amend the Charter to expand the methods that the Company may employ to not become subject to the “penny stock” rules of the Securities and Exchange Commission, and (iii) a proposal to allow the Company, without further stockholder approval, to amend (the “Trust Liquidation Amendment”) the Charter to delete the various provisions applicable only to special purpose acquisition corporations and provide for the liquidation of the trust account established in connection with the Company’s initial public offering. If the Second Extension Amendment proposal and the Trust Liquidation Amendment proposal are both approved by the stockholders, the Company’s board of directors reserves the right to determine, in its sole discretion, which charter amendment to implement following the special meeting. In the event the Second Extension Amendment is implemented, the Trust Liquidation Amendment will not be implemented and will be abandoned, and vice versa.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (this “Quarterly Report”) to “we,” “us” or the “Company” refer to Roth CH Acquisition V Co. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the search for an initial business combination, the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and the Company’s final prospectus for its initial public offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company formed under the laws of the State of Delaware on November 5, 2020, for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering (as defined below) and the sale of the Private Units (as defined below), our capital stock, debt or a combination of cash, stock and debt.

The issuance of additional shares of our stock in an initial business combination:

	●	may significantly reduce the equity interest of our stockholders;

	●	may subordinate the rights of holders of common stock if we issue preferred shares with rights senior to those afforded to our shares of common stock;

	●	will likely cause a change in control if a substantial number of our shares of common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and most likely will also result in the resignation or removal of our present officers and directors; and

	●	may adversely affect prevailing market prices for our securities.

Similarly, if we issue debt securities or otherwise incur significant indebtedness, it could result in:

	●	default and foreclosure on our assets if our operating revenues after a business combination are insufficient to pay our debt obligations;

	●	acceleration of our obligations to repay the indebtedness even if we have made all principal and interest payments when due if the debt security contains covenants that required the maintenance of certain financial ratios or reserves and we breach any such covenant without a waiver or renegotiation of that covenant;

	●	our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand; and

	●	our inability to obtain additional financing, if necessary, if the debt security contains covenants restricting our ability to obtain additional financing while such security is outstanding.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial business combination will be successful.

Recent Developments

On May 17, 2023, we held a special meeting of stockholders (the “Special Meeting”), at which our stockholders approved an amendment (the “Extension Amendment”) to the Company’s amended and restated certificate of incorporation to give the Company the right to extend the date by which the Company has to consummate a business combination up to six (6) times, each such extension for an additional one (1) month period, from June 3, 2023 to December 4, 2023.

On May 3 and 4, 2023, we entered into non-redemption agreements with certain stockholders owning, in the aggregate, 2,000,000 shares of the Company’s common stock, pursuant to which such stockholders agreed, among other things, not to redeem or exercise any right to redeem such public shares in connection with the Extension Amendment. Certain initial stockholders of the Company agreed to pay the stockholders that entered into such agreements $0.04 per share for each one-month extension in connection with such agreements. On July 20, 2023, we entered into amendments to the non-redemption agreements to provide that the Company or certain initial stockholders of the Company, or their affiliates or designees, will pay such stockholders that entered into such non-redemption agreements $0.04 per share for each one-month extension in connection with such agreements. On May 30, 2023, June 29, 2023, July 31, 2023, August 31, 2023, October 2, 2023 and November 6, 2023, we issued payments to the Non-redeeming Stockholders in the aggregate amount of $480,000 in relation to the extension of the Combination Period through December 4, 2023. The Company also recorded a liability due to Non-redeeming Stockholders related to the remaining one-month extension periods and determined that the fair value of the liability as of September 20, 2023 was $151,189.

On November 8, 2023, we filed a preliminary proxy statement in connection with a special meeting of stockholders, at which our stockholders will consider and vote upon (i) a proposal to allow the Company, without further stockholder approval, to amend (the “Second Extension Amendment”) our amended and restated certificate of incorporation (the “Charter”), to extend the date by which we have to consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period, from December 4, 2023 to December 3, 2024 (i.e., for a period of time ending 36 months after the consummation of our initial public offering); (ii) a proposal to amend the Charter to expand the methods that we may employ to not become subject to the “penny stock” rules of the Securities and Exchange Commission, and (iii) a proposal to allow the Company, without further stockholder approval, to amend (the “Trust Liquidation Amendment”) the Charter to delete the various provisions applicable only to special purpose acquisition corporations and provide for the liquidation of the trust account established in connection with our initial public offering. If the Second Extension Amendment proposal and the Trust Liquidation Amendment proposal are both approved by the stockholders, our board of directors reserves the right to determine, in its sole discretion, which charter amendment to implement following the special meeting. In the event the Second Extension Amendment is implemented, the Trust Liquidation Amendment will not be implemented and will be abandoned, and vice versa.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities through September 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering described below, and subsequent to the Initial Public Offering, identifying a target company for an initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination, at the earliest. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account (as defined below). We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, an initial business combination.

For the three months ended September 30, 2023, we had a net loss of $646,092, which consisted of interest earned on marketable securities held in Trust Account of $343,491 and change in fair value of due to non-redeeming stockholders of $8,811, offset by of operating costs of $908,357 and provision for income taxes of $90,037.

For the three months ended September 30, 2022, we had a net income of $304,331, which consisted of interest earned on marketable securities held in Trust Account of $526,853, offset by of operating costs of $122,934 and provision for income taxes of $99,588.

For the nine months ended September 30, 2023, we had a net income of $156,857, which consisted of interest earned on marketable securities held in Trust Account of $2,641,366, offset by of operating costs of $1,293,488, provision for income taxes of $719,832 and finance costs for non-redemption agreements of $471,189.

For the nine months ended September 30, 2022, we had a net income of $163,259, which consisted of interest earned on marketable securities held in Trust Account of $697,289, offset by of operating costs of $416,559 and provision for income taxes of $117,471.

Liquidity and Capital Resources

On December 3, 2021, we consummated our initial public offering (the “Initial Public Offering”) of 11,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $115,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 461,500 units (the “Private Units”), at a price of $10.00 per Private Unit, in a private placement to certain of the holders of ours shares prior to the Initial Public Offering (the “Initial Stockholders”), generating gross proceeds of $4,615,000.

Following the Initial Public Offering, including the full exercise of the over-allotment option by the underwriters, and the sale of the Private Units, a total of $116,725,000 was placed in a trust account located in the United States (the “Trust Account”). We incurred $1,625,220 in transaction costs, consisting of $1,150,000 of underwriting fees and $475,220 of other offering costs.

For the nine months ended September 30, 2023, cash used in operating activities was $1,800,678. Net income of $156,857 was affected by interest earned on marketable securities held in the Trust Account of $2,641,366 offset by fair value of due to non-redeeming shareholders of $471,189, and changes in operating assets and liabilities, which provided $212,642.

For the nine months ended September 30, 2022, cash used in operating activities was $214,324. Net income of $163,259 was affected by interest earned on marketable securities held in the Trust Account of $697,289 and changes in operating assets and liabilities, which provided $319,706.

On May 31, 2023, in connection with the stockholders’ vote at the Special Meeting, stockholders exercised their right to redeem 8,989,488 shares of common stock and $93,010,772 was released from the Trust account in connection with the share redemption. In connection with the share redemption, we recorded $930,108 of excise tax liability calculated as 1% of shares redeemed on May 31, 2023. As of September 30, 2023, we had cash and marketable securities held in the Trust Account of $26,368,415. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our initial business combination. We may withdraw interest to pay taxes. Through September 30, 2023, we withdrew $1,328,243 of interest income from the Trust Account. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of September 30, 2023, we had $112,941 of cash held outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete an initial business combination.

In order to finance transaction costs in connection with an initial business combination, the Initial Stockholders, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). If we complete an initial business combination, we would repay the Working Capital Loans out of the proceeds of the Trust Account released to us. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that an initial business combination does not close, we may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would be repaid upon consummation of an initial business combination, without interest. As of September 30, 2023, there were $250,000 of Working Capital Loans outstanding.

On July 26, 2023, we issued an unsecured promissory note in the aggregate amount of up to $750,000 (the “Note”) to individuals or entities listed on the Note. The Note is non-interest bearing and is payable on the earlier of (i) the date on which the Company consummates an initial business combination or (ii) the date the Company liquidates if a Business Combination is not consummated. The Note will be repaid only from amounts remaining outside of the Company’s Trust Account, if any. The proceeds will be used by the Company to pay various expenses of the Company, including the extension payments, and for general corporate purposes.

If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such initial business combination.

Going Concern

We will need to raise additional capital through loans or additional investments from the Initial Stockholders and our officers and directors. The Initial Stockholders and our officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all. If an initial business combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. These conditions raise substantial doubt about our ability to continue as a going concern one year from the date that these financial statements are issued. We plan to address this uncertainty through working capital loans and through consummation of our initial business combination. There is no assurance that working capital loans will be available to the Company or that our plans to consummate a business combination will be successful; therefore, there is substantial doubt about our ability to continue as a going concern. There is no assurance that working capital loans will be available to us or that our plans to consummate an initial business combination will be successful.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2023. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as described below.

Pursuant to a business combination marketing agreement entered into on November 30, 2021, we have engaged Roth Capital Partners, LLC (“Roth”) and Craig-Hallum Capital Group LLC (“Craig-Hallum”), the underwriters in the Initial Public Offering, as advisors in connection with our initial business combination to assist in the transaction structuring and negotiation of a definitive purchase agreement with respect to the initial business combination, hold meetings with the stockholders to discuss the initial business combination and the target’s attributes, introduce us to potential investors to purchase our securities in connection with the initial business combination, and assist with financial analysis, presentations, press releases and filings related to the initial business combination. We will pay Roth and Craig-Hallum a fee for such services upon the consummation of an initial business combination in an amount equal to, in the aggregate, 4.5% of the gross proceeds of the Initial Public Offering (or $5,175,000 in the aggregate). As a result, Roth and Craig-Hallum will not be entitled to such fee unless we consummate an initial business combination.

Critical Accounting Policies

There have been no material changes in the critical accounting estimates disclosed under Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates contained in the Annual Report on Form 10-K for the year ended December 31, 2022.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to make disclosures under this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including the chief executive officers and chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officers and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2023, our disclosure controls and procedures were effective.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

As a smaller reporting company, we are not required to make disclosures under this Item. We have provided a comprehensive list of risk factors in our Annual Report on Form 10 K for the year ended December 31, 2022, as filed with the SEC.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
31.1*		Certification of Principal Executive Officers Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Accounting and Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officers Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

Filed herewith.

Furnished herewith. This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ROTH CH ACQUISITION V CO.

Date: November 20, 2023	By:	/s/ Byron Roth
	Name:	Byron Roth
	Title:	Co-Chief Executive Officer and Co-Chairman of the Board
		(Co-Principal Executive Officer)

Date: November 20, 2023	By:	/s/ John Lipman
	Name:	John Lipman
	Title:	Co-Chief Executive Officer and Co-Chairman of the Board
		(Co-Principal Executive Officer)

Date: November 20, 2023	By:	/s/ Gordon Roth
	Name:	Gordon Roth
	Title:	Chief Financial Officer
		(Principal Accounting and Financial Officer)

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICERS

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

We, Byron Roth and John Lipman, each certify that:

I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of Roth CH Acquisition V Co.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 20, 2023

	/s/ Byron Roth
	Byron Roth
	Co-Chief Executive Officer and Co-Chairman of the Board
	(Co-Principal Executive Officer)

	/s/ John Lipman
	John Lipman
	Co-Chief Executive Officer and Co-Chairman of the Board
	(Co-Principal Executive Officer)

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL ACCOUNTING AND FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gordon Roth, certify that:

I have reviewed this quarterly report on Form 10-Q for the quarterly period ended September 30, 2023 of Roth CH Acquisition V Co.;

(Paragraph omitted pursuant to Exchange Act Rules 13a-14(a) and 15d-15(a));

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 20, 2023

	/s/ Gordon Roth
	Gordon Roth
	Chief Financial Officer
	(Principal Accounting and Financial Officer)

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Roth CH Acquisition V Co. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), we, Byron Roth and John Lipman, Co-Chief Executive Officers and Co-Chairmen of the Board of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of our knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 20, 2023

	/s/ Byron Roth
	Byron Roth
	Co-Chief Executive Officer and Co-Chairman of the Board
	(Co-Principal Executive Officer)

	/s/ John Lipman
	John Lipman
	Co-Chief Executive Officer and Co-Chairman of the Board
	(Co-Principal Executive Officer)

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Roth CH Acquisition V Co. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Gordon Roth, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 20, 2023

	/s/ Gordon Roth
	Gordon Roth
	Chief Financial Officer
	(Principal Accounting and Financial Officer)

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2023	Nov. 20, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-41105
Entity Registrant Name	ROTH CH ACQUISITION V CO.
Entity Central Index Key	0001885998
Entity Tax Identification Number	86-1229207
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	888 San Clemente Drive
Entity Address, Address Line Two	Suite 400
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92660
City Area Code	(949)
Local Phone Number	720-5700
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		5,847,012
Common Stock [Member]
Title of 12(b) Security	Common Stock
Trading Symbol	ROCL
Security Exchange Name	NASDAQ
Warrants
Title of 12(b) Security	Warrants
Trading Symbol	ROCLW
Security Exchange Name	NASDAQ
Units
Title of 12(b) Security	Units
Trading Symbol	ROCLU
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 112,941	$ 687,471
Prepaid expenses	76,766	150,250
Cash and marketable securities held in Trust Account	26,711,906	118,377,460
Total Current Assets	26,901,613	119,215,181
Total Assets	26,901,613	119,215,181
Current liabilities
Accrued expenses	733,415	224,719
Due to Non-redeeming Stockholders	151,189
Promissory note – related party	250,000
Excise taxes payable	930,108
Income taxes payable	51,673	421,211
Total Current Liabilities	2,116,385	645,930
Common stock subject to possible redemption, $0.0001 par value; 2,510,512 and 11,500,000 shares at $10.59 per share and $10.24 per share redemption value as of September 30, 2023 and December 31, 2022, respectively	26,591,561	117,809,374
Stockholders’ (Deficit) Equity
Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,336,500 shares issued and outstanding (excluding 2,510,512 and 11,500,000 shares subject to possible redemption) as of September 30, 2023 and December 31, 2022, respectively	334	334
Additional paid-in capital		205,072
Accumulated (deficit) earnings	(1,806,667)	554,471
Total Stockholders’ (Deficit) Equity	(1,806,333)	759,877
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 26,901,613	$ 119,215,181

CONDENSED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Common stock subject to possible redemption, outstanding (in shares)	2,510,512	11,500,000
Common stock, par value (per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	3,336,500	3,336,500
Common stock, shares outstanding	3,336,500	3,336,500
Common Stock Subject To Possible Redemption [Member]
Common stock subject to possible redemption, par value (per share)	$ 0.0001	$ 0.0001
Common stock subject to possible redemption, outstanding (in shares)	2,510,512	11,500,000
Common stock subject to possible redemption, redemption value (per share)	$ 10.59	$ 10.24

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
General and administrative expenses	$ 908,357	$ 122,934	$ 1,293,488	$ 416,559
Loss from operations	(908,357)	(122,934)	(1,293,488)	(416,559)
Other income (expense)
Interest earned on marketable securities held in Trust Account	343,491	526,853	2,641,366	697,289
Change in fair value of due to non-redeeming stockholders	8,811		(471,189)
Total other income, net	352,302	526,853	2,170,177	697,289
(Loss) Income before provision for income taxes	(556,055)	403,919	876,689	280,730
Provision for income taxes	(90,037)	(99,588)	(719,832)	(117,471)
Net (loss) income	$ (646,092)	$ 304,331	$ 156,857	$ 163,259
Basic and diluted weighted average shares outstanding, common stock subject to possible redemption	2,510,512	11,500,000	7,482,720	11,500,000
Basic and diluted net (loss) income per common share, common stock subject to possible redemption	(0.07)	0.03	0.13	0.02
Basic and diluted weighted average shares outstanding, non-redeemable common stock	$ 3,336,500	$ 3,336,500	$ 3,336,500	$ 3,336,500
Basic and diluted net (loss) income per share, non-redeemable common stock	$ (0.14)	$ (0.00)	$ (0.24)	$ (0.02)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance — June 30, 2022 at Dec. 31, 2021	$ 334	$ 1,289,446	$ (167,644)	$ 1,122,136
Beginning Balance, Shares at Dec. 31, 2021	3,336,500
Net income			(151,738)	(151,738)
Balance — September 30, 2022 at Mar. 31, 2022	$ 334	1,289,446	(319,382)	970,398
Ending Balance, Shares at Mar. 31, 2022	3,336,500
Accretion of carrying value to redemption value		(72,983)		(72,983)
Net income			10,666	10,666
Balance — September 30, 2022 at Jun. 30, 2022	$ 334	1,216,463	(308,716)	908,081
Ending Balance, Shares at Jun. 30, 2022	3,336,500
Accretion of carrying value to redemption value		(369,382)		(369,382)
Net income			304,331	304,331
Balance — September 30, 2022 at Sep. 30, 2022	$ 334	847,081	(4,385)	843,030
Ending Balance, Shares at Sep. 30, 2022	3,336,500
Balance — June 30, 2022 at Dec. 31, 2022	$ 334	205,072	554,471	759,877
Beginning Balance, Shares at Dec. 31, 2022	3,336,500
Accretion of carrying value to redemption value		(205,072)	(669,501)	(874,573)
Net income			708,556	708,556
Balance — September 30, 2022 at Mar. 31, 2023	$ 334		593,526	593,860
Ending Balance, Shares at Mar. 31, 2023	3,336,500
Accretion of carrying value to redemption value			(729,454)	(729,454)
Excise taxes on stock redemption			(930,108)	(930,108)
Net income			94,393	94,393
Balance — September 30, 2022 at Jun. 30, 2023	$ 334		(971,643)	(971,309)
Ending Balance, Shares at Jun. 30, 2023	3,336,500
Accretion of carrying value to redemption value			(188,932)	(188,932)
Net income			(646,092)	(646,092)
Balance — September 30, 2022 at Sep. 30, 2023	$ 334		$ (1,806,667)	$ (1,806,333)
Ending Balance, Shares at Sep. 30, 2023	3,336,500

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income	$ 156,857	$ 163,259
Adjustment to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(2,641,366)	(697,289)
Change in fair value of due to non-redeeming stockholders	471,189
Changes in operating assets and liabilities:
Prepaid expenses	73,484	130,158
Accrued expenses	508,696	72,077
Income taxes payable	(369,538)	117,471
Net cash used in operating activities	(1,800,678)	(214,324)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account to pay franchise and income taxes	1,296,148
Cash withdrawn from Trust Account in connection with redemption	93,010,772
Net cash provided by investing activities	94,306,920
Cash Flows from Financing Activities:
Proceeds from promissory note - related party	250,000
Payments to non-redeeming stockholders	(320,000)
Redemption of common stock	(93,010,772)
Net cash used in financing activities	(93,080,772)
Net Change in Cash	(574,530)	(214,324)
Cash – Beginning of period	687,471	898,895
Cash – End of period	112,941	684,571
Non-cash financing activities:
Change in value of Class A common stock subject to possible redemption	1,792,959	442,365
Excise taxes on stock redemption	930,108
Supplemental information
Income taxes paid	$ 1,089,370

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Transaction costs amounted to $1,625,220, consisting of $1,150,000 of underwriting fees, and $475,220 of other offering costs.

Liquidity and Going Concern

As of September 30, 2023, the Company had $112,941 in its operating bank account and a working capital deficit of $1,926,678.

Risks and Uncertainties

Inflation Reduction Act of 2022

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U. S. Treasury securities.

Common Stock Subject to Possible Redemption

At September 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected in the balance sheets is reconciled in the following table:


Gross proceeds	$	115,000,000
Less:
Common stock issuance costs		(1,625,220	)
Plus:
Accretion of carrying value to redemption value		3,350,220
Common stock subject to possible redemption, December 31, 2021		116,725,000
Plus:
Accretion of carrying value to redemption value		1,084,374
Common stock subject to possible redemption, December 31, 2022		117,809,374
Less:
Shares Redeemed		(93,010,772	)
Plus:
Accretion of carrying value to redemption value		1,792,959
Common stock subject to possible redemption, September 30, 2023	$	26,591,561

Income Taxes

Net (Loss) Income per Common Share

The following tables reflect the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts):


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2023			2022			2023			2022
Net (loss) income	$	(646,092	)	$	304,331		$	156,857		$	163,259
Accretion of redeemable common stock to redemption amount		(188,932	)		(369,382	)		(1,792,959	)		(442,365	)
Excise taxes on stock redemption		-			-			(930,108	)		-
Net loss including accretion of temporary equity to redemption value and excise taxes on stock redemption	$	(835,024	)	$	(65,051	)	$	(2,566,210	)	$	(279,106	)


	For the Three Months Ended September 30,												For the Nine Months Ended September 30,
	2023						2022						2023						2022
	Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable
	Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock
Basic and diluted net (loss) income per common share
Numerator:
Allocation of net loss including accretion of temporary equity to redemption value	$	(358,531	)	$	(476,493	)	$	(50,422	)	$	(14,629	)	$	(1,774,826	)	$	(791,384	)	$	(216,339	)	$	(62,767	)
Accretion of common stock to redemption value		188,932			-			369,382			-		$	1,792,959			-			442,365			-
Excise taxes on stock redemption		-			-			-			-			930,108			-			-			-
Net (loss) income	$	(169,599	)	$	(476,493	)	$	318,960		$	(14,629	)	$	948,241		$	(791,384	)	$	226,026		$	(62,767	)
Denominator:
Basic and diluted weighted average shares outstanding		2,510,512			3,336,500			11,500,000			3,336,500			7,482,720			3,336,500			11,500,000			3,336,500
Basic and diluted net (loss) income per common share	$	(0.07	)	$	(0.14	)	$	0.03		$	(0.00	)	$	0.13		$	(0.24	)	$	0.02		$	(0.02	)

Concentration of Credit Risk

Fair Value of Financial Instruments

Warrant Classification

INITIAL PUBLIC OFFERING

9 Months Ended

Sep. 30, 2023

Initial Public Offering

INITIAL PUBLIC OFFERING

NOTE 3. INITIAL PUBLIC OFFERING

PRIVATE PLACEMENT

9 Months Ended

Sep. 30, 2023

Private Placement

PRIVATE PLACEMENT

NOTE 4. PRIVATE PLACEMENT

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2023

RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

Working Capital Loans

Underwriting Agreement and Business Combination Marketing Agreement

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Underwriting Agreement

The underwriters received an underwriting discount of 1.0% of the gross proceeds of the Initial Public Offering, or $1,150,000.

Business Combination Marketing Agreement

STOCKHOLDERS’ EQUITY

9 Months Ended

Sep. 30, 2023

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 7. STOCKHOLDERS’ EQUITY

Warrants — At September 30, 2023 and December 31, 2022, there were 5,750,000 Public Warrants outstanding and 230,750 Private Warrants outstanding.

The Company may redeem the Public Warrants:

	●	in whole and not in part;

	●	at a price of $0.01 per warrant;

	●	at any time after the warrants become exercisable;

	●	upon not less than 30 days’ prior written notice of redemption to each warrant holder;

	●	if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share, for any 20 trading days within a 30-day trading period commencing after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

●

Except with respect to certain registration rights and transfer restrictions, the Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering.

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.


		September 30,		December 31,
Description	Level	2023		2022
Assets:
U.S. Mutual Funds Held in Trust Account	1	$	26,711,906	$	118,377,460

Liabilities:
Due to non-redeeming stockholders	3	$	151,189	$	-

Due to Non-redeeming Stockholders

The following table presents the changes in the fair value of Level 3 liability due to Non-redeeming Stockholders:


Fair value as of December 31, 2022	$	-
Initial value		480,000
Payments to Non-redeeming Stockholders		(320,000	)
Change in fair value of due to Non-redeeming Stockholders		(8,811	)
Fair value as of September 30, 2023	$	151,189

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

On October 2, 2023, October 3, 2023, October 10, 2023, and October 11, 2023, the Company drew additional amounts in the aggregate of $149,859 on the Note.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Use of Estimates

Use of Estimates

Cash and Cash Equivalents

Cash and Cash Equivalents

Marketable Securities Held in Trust Account

Marketable Securities Held in Trust Account

At September 30, 2023 and December 31, 2022, all of the assets held in the Trust Account were held in money market funds which are invested primarily in U. S. Treasury securities.

Common Stock Subject to Possible Redemption

Common Stock Subject to Possible Redemption

At September 30, 2023 and December 31, 2022, the common stock subject to possible redemption reflected in the balance sheets is reconciled in the following table:


Gross proceeds	$	115,000,000
Less:
Common stock issuance costs		(1,625,220	)
Plus:
Accretion of carrying value to redemption value		3,350,220
Common stock subject to possible redemption, December 31, 2021		116,725,000
Plus:
Accretion of carrying value to redemption value		1,084,374
Common stock subject to possible redemption, December 31, 2022		117,809,374
Less:
Shares Redeemed		(93,010,772	)
Plus:
Accretion of carrying value to redemption value		1,792,959
Common stock subject to possible redemption, September 30, 2023	$	26,591,561

Income Taxes

Income Taxes

Net (Loss) Income per Common Share

Net (Loss) Income per Common Share

The following tables reflect the calculation of basic and diluted net (loss) income per common share (in dollars, except per share amounts):


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2023			2022			2023			2022
Net (loss) income	$	(646,092	)	$	304,331		$	156,857		$	163,259
Accretion of redeemable common stock to redemption amount		(188,932	)		(369,382	)		(1,792,959	)		(442,365	)
Excise taxes on stock redemption		-			-			(930,108	)		-
Net loss including accretion of temporary equity to redemption value and excise taxes on stock redemption	$	(835,024	)	$	(65,051	)	$	(2,566,210	)	$	(279,106	)


	For the Three Months Ended September 30,												For the Nine Months Ended September 30,
	2023						2022						2023						2022
	Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable
	Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock
Basic and diluted net (loss) income per common share
Numerator:
Allocation of net loss including accretion of temporary equity to redemption value	$	(358,531	)	$	(476,493	)	$	(50,422	)	$	(14,629	)	$	(1,774,826	)	$	(791,384	)	$	(216,339	)	$	(62,767	)
Accretion of common stock to redemption value		188,932			-			369,382			-		$	1,792,959			-			442,365			-
Excise taxes on stock redemption		-			-			-			-			930,108			-			-			-
Net (loss) income	$	(169,599	)	$	(476,493	)	$	318,960		$	(14,629	)	$	948,241		$	(791,384	)	$	226,026		$	(62,767	)
Denominator:
Basic and diluted weighted average shares outstanding		2,510,512			3,336,500			11,500,000			3,336,500			7,482,720			3,336,500			11,500,000			3,336,500
Basic and diluted net (loss) income per common share	$	(0.07	)	$	(0.14	)	$	0.03		$	(0.00	)	$	0.13		$	(0.24	)	$	0.02		$	(0.02	)

Concentration of Credit Risk

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Warrant Classification

Warrant Classification

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Schedule of reconciliation of common stock subject to possible redemption reflected in the balance sheets


Gross proceeds	$	115,000,000
Less:
Common stock issuance costs		(1,625,220	)
Plus:
Accretion of carrying value to redemption value		3,350,220
Common stock subject to possible redemption, December 31, 2021		116,725,000
Plus:
Accretion of carrying value to redemption value		1,084,374
Common stock subject to possible redemption, December 31, 2022		117,809,374
Less:
Shares Redeemed		(93,010,772	)
Plus:
Accretion of carrying value to redemption value		1,792,959
Common stock subject to possible redemption, September 30, 2023	$	26,591,561

Schedule of calculation of basic and diluted net income (loss) per common share


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2023			2022			2023			2022
Net (loss) income	$	(646,092	)	$	304,331		$	156,857		$	163,259
Accretion of redeemable common stock to redemption amount		(188,932	)		(369,382	)		(1,792,959	)		(442,365	)
Excise taxes on stock redemption		-			-			(930,108	)		-
Net loss including accretion of temporary equity to redemption value and excise taxes on stock redemption	$	(835,024	)	$	(65,051	)	$	(2,566,210	)	$	(279,106	)


	For the Three Months Ended September 30,												For the Nine Months Ended September 30,
	2023						2022						2023						2022
	Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable			Redeemable			Non-redeemable
	Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock			Common stock
Basic and diluted net (loss) income per common share
Numerator:
Allocation of net loss including accretion of temporary equity to redemption value	$	(358,531	)	$	(476,493	)	$	(50,422	)	$	(14,629	)	$	(1,774,826	)	$	(791,384	)	$	(216,339	)	$	(62,767	)
Accretion of common stock to redemption value		188,932			-			369,382			-		$	1,792,959			-			442,365			-
Excise taxes on stock redemption		-			-			-			-			930,108			-			-			-
Net (loss) income	$	(169,599	)	$	(476,493	)	$	318,960		$	(14,629	)	$	948,241		$	(791,384	)	$	226,026		$	(62,767	)
Denominator:
Basic and diluted weighted average shares outstanding		2,510,512			3,336,500			11,500,000			3,336,500			7,482,720			3,336,500			11,500,000			3,336,500
Basic and diluted net (loss) income per common share	$	(0.07	)	$	(0.14	)	$	0.03		$	(0.00	)	$	0.13		$	(0.24	)	$	0.02		$	(0.02	)

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of company's assets that are measured at fair value on a recurring basis


		September 30,		December 31,
Description	Level	2023		2022
Assets:
U.S. Mutual Funds Held in Trust Account	1	$	26,711,906	$	118,377,460

Liabilities:
Due to non-redeeming stockholders	3	$	151,189	$	-

Schedule of changes in the fair value of Level 3 liability due to Non-redeeming Stockholders


Fair value as of December 31, 2022	$	-
Initial value		480,000
Payments to Non-redeeming Stockholders		(320,000	)
Change in fair value of due to Non-redeeming Stockholders		(8,811	)
Fair value as of September 30, 2023	$	151,189

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)			3 Months Ended	9 Months Ended		12 Months Ended
	May 17, 2023 Integer	Dec. 03, 2021 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) Integer $ / shares shares	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)	Nov. 06, 2023 USD ($)	Jul. 26, 2023 USD ($)	Jul. 20, 2023 $ / shares	Jun. 02, 2023 USD ($)	May 03, 2023 $ / shares shares	Dec. 31, 2022 USD ($) shares	Aug. 16, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of businesses minimum \| Integer				1
Proceeds from issuance initial public offering						$ 115,000,000
Sale of private placement units (in shares) \| shares			5,980,750	5,980,750
Transaction costs			$ 1,625,220	$ 1,625,220
Underwriting fees			1,150,000	1,150,000
Other offering costs			475,220	$ 475,220
Assets held in the Trust Account (in percentage)				80
Condition for future business combination threshold ownership (in percentage)				50
Minimum of net tangible assets			$ 5,000,001	$ 5,000,001
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)				100.00%
Number of shares exercised to redeem \| shares				8,989,488
Aggregate price \| $ / shares			$ 10.36	$ 10.36
Value shares exercised to redeem				$ 93,010,772
Balance in trust account			$ 26,711,906	$ 26,711,906						$ 27,077,077		$ 118,377,460
Common Stock, Shares, Outstanding \| shares			3,336,500	3,336,500								3,336,500
Due to non redeeming stockholders current			$ 151,189	$ 151,189
Due to non-redeeming stockholders			8,811	471,189
Operating bank account			112,941	112,941								$ 687,471
Working capital				1,926,678
Proceeds from promissory note - related party				250,000
Excise tax													1.00%
Estimated potential excise tax liability			$ 930,108	$ 930,108
Percentage of estimated potential excise tax liabiliy on shares redeemed			100.00%	100.00%
Unsecured Promissory Notes [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Aggregate amount								$ 750,000
Extension Amendment [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of times up to which the business combination is consummated \| Integer	6
Period of extension amendment allowed	1 month
Non-Redemption Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common Stock, Shares, Outstanding \| shares											2,000,000
Price Per Share Agreed To Non-Redeeming Shareholders By Initial Stockholders \| $ / shares									$ 0.04		$ 0.04
Non-Redemption Agreements [Member] \| Subsequent Event [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments To Non-Redeemable Stockholders, In Relation To Extension Of Combination							$ 480,000
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of units sold \| shares		11,500,000
purchase price, per Unit \| $ / shares		$ 10.15
Proceeds from issuance initial public offering		$ 115,000,000
Net proceeds of the sale of the Units		$ 116,725,000
Over-Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of units sold \| shares		1,500,000
purchase price, per Unit \| $ / shares		$ 10.00
Private Placement [Member] \| Private Units [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sale of private placement units (in shares) \| shares		461,500
Price of per Unit \| $ / shares		$ 10.00
Gross proceeds		$ 4,615,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common stock subject to possible redemption (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Gross proceeds			$ 115,000,000
Common stock issuance costs			(1,625,220)
Accretion of carrying value to redemption value	$ 1,792,959	$ 1,084,374	3,350,220
Common stock subject to possible redemption, beginning	117,809,374	116,725,000
Shares Redeemed	(93,010,772)
Common stock subject to possible redemption, ending	$ 26,591,561	$ 117,809,374	$ 116,725,000

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted net income (loss) per common share (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Net (loss) income	$ (646,092)	$ 304,331	$ 156,857	$ 163,259
Accretion of redeemable common stock to redemption amount	(188,932)	(369,382)	(1,792,959)	(442,365)
Excise taxes on stock redemption			(930,108)
Allocation of net loss including accretion of temporary equity to redemption value	(835,024)	(65,051)	(2,566,210)	(279,106)
Accretion of common stock to redemption value			1,792,959		$ 1,084,374	$ 3,350,220
Redeemable Common Stock [Member]
Net (loss) income	(169,599)	318,960	948,241	226,026
Excise taxes on stock redemption			930,108
Allocation of net loss including accretion of temporary equity to redemption value	(358,531)	(50,422)	(1,774,826)	(216,339)
Accretion of common stock to redemption value	$ 188,932	$ 369,382	$ 1,792,959	$ 442,365
Basic and diluted weighted average shares outstanding	2,510,512	11,500,000	7,482,720	11,500,000
Basic and diluted net (loss) income per common share	$ (0.07)	$ 0.03	$ 0.13	$ 0.02
Non Redeemable Common Stock [Member]
Net (loss) income	$ (476,493)	$ (14,629)	$ (791,384)	$ (62,767)
Excise taxes on stock redemption
Allocation of net loss including accretion of temporary equity to redemption value	(476,493)	(14,629)	(791,384)	(62,767)
Accretion of common stock to redemption value
Basic and diluted weighted average shares outstanding	3,336,500	3,336,500	3,336,500	3,336,500
Basic and diluted net (loss) income per common share	$ (0.14)	$ (0.00)	$ (0.24)	$ (0.02)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash equivalents	$ 0		$ 0		$ 0
Additional paid-in capital					$ 205,072
Effective tax rate	16.19%	24.66%	82.11%	41.84%
Statutory tax rate (as a percent)	21.00%	21.00%	21.00%	21.00%
Unrecognized Tax Benefits	$ 0		$ 0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$ 0		$ 0
Number of warrants to purchase shares issued	5,980,750		5,980,750
Additional Paid-in Capital [Member]
Additional paid-in capital	$ 0		$ 0

INITIAL PUBLIC OFFERING (Details Narrative)	Dec. 03, 2021 $ / shares shares
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units sold	11,500,000
purchase price, per Unit \| $ / shares	$ 10.15
Number of shares in a unit	1
IPO [Member] \| Public Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares issuable per warrant	1
Exercise price of warrants \| $ / shares	$ 11.50
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of units sold	1,500,000
purchase price, per Unit \| $ / shares	$ 10.00

PRIVATE PLACEMENT (Details Narrative) - USD ($)	Dec. 03, 2021	Sep. 30, 2023
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued		5,980,750
Private Units [Member] \| Private Placement [Member]
Class of Warrant or Right [Line Items]
Number of warrants to purchase shares issued	461,500
Price of warrants	$ 10.00
Aggregate purchase price	$ 4,615,000
Number of shares per unit	1
Private Warrants [Member] \| Private Placement [Member]
Class of Warrant or Right [Line Items]
Number of shares per warrant	1
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS (Details Narrative)		1 Months Ended		9 Months Ended
RELATED PARTY TRANSACTIONS (Details Narrative)	Nov. 22, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Sep. 30, 2023 USD ($) Integer $ / shares	Jul. 26, 2023 USD ($)	Dec. 31, 2022 USD ($)
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Aggregate amount					$ 750,000
Maximum [Member] \| Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Aggregate amount					$ 750,000
Founder Shares [Member] \| Sponsor [Member]
Related Party Transaction [Line Items]
Number of shares issued \| shares		110,302	4,312,500
Aggregate purchase price		$ 959	$ 25,000
Number of shares bought back \| shares		1,547,802
Value of shares bought back		$ 959
Number of shares cancelled \| shares		1,437,500
Aggregate number of shares owned \| shares		2,875,000
Percentage of transfer of founder shares with certain exceptions				50.00%
Restrictions on transfer period of time after business combination completion				6 months
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares				$ 12.50
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| Integer				20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| Integer				30
Percentage of transfer of remaining founder shares with certain exceptions				50.00%
Founder Shares [Member] \| CR Financial Holdings, Inc [Member]
Related Party Transaction [Line Items]
Number of shares issued \| shares	56,932
Aggregate purchase price	$ 495
Founder Shares [Member] \| Initial Stockholders and Independent Directors [Member]
Related Party Transaction [Line Items]
Number of shares issued \| shares	167,234
Fair value upon the grant date	$ 788,900
Fair value upon the grant date (per share) \| $ / shares	$ 4.72
Stock-based compensation expense recognized				$ 0
Working Capital Loans With Related Party [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Working capital loan outstanding				$ 250,000		$ 0

COMMITMENTS AND CONTINGENCIES (Details Narrative)	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Details Narrative)	Sep. 30, 2023 USD ($)
Subsidiary, Sale of Stock [Line Items]
Minimum period of piggy-back registration rights	5 years
Maximum period of piggy-back registration rights	7 years
Fee payable on aggregate gross proceeds (as percentage)	4.50%
Aggregated gross proceeds amount of advisory fee payable	$ 5,175,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Underwriting discount (in percentage)	1.00%
Underwriting discount	$ 1,150,000

STOCKHOLDERS’ EQUITY (Details Narrative)	9 Months Ended
STOCKHOLDERS’ EQUITY (Details Narrative)	Sep. 30, 2023 Integer $ / shares shares	May 31, 2023 shares	Dec. 31, 2022 $ / shares shares
Class of Warrant or Right [Line Items]
Common stock, shares authorized	50,000,000		50,000,000
Common stock, par value (per share) \| $ / shares	$ 0.0001		$ 0.0001
Right to redeem shares of common stock		8,989,488
Common stock, shares issued	3,336,500		3,336,500
Common stock, shares outstanding	3,336,500		3,336,500
Common stock subject to possible redemption, outstanding (in shares)	2,510,512		11,500,000
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	5,750,000		5,750,000
Warrants exercisable term from the completion of business combination	30 days
Number of days of which warrants will not be effective from the date of business combination	120 days
Public Warrants expiration term	5 years
Redemption price per public warrant (in dollars per share) \| $ / shares	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Warrant Redemption Condition Minimum Share Price \| $ / shares	$ 18.00
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants \| Integer	30
Redemption period	30 days
Share price trigger used to measure dilution of warrant \| $ / shares	$ 9.20
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	0.60
Trading period after business combination used to measure dilution of warrant \| Integer	20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Adjustment of redemption price of stock based on newly issued price 2 (as a percent)	180.00%
Private Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	230,750		230,750

FAIR VALUE MEASUREMENTS (Details) - Fair Value, Recurring [Member] - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 1 [Member] \| U.S. Mutual Funds Held in Trust Account [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	$ 26,711,906	$ 118,377,460
Fair Value, Inputs, Level 3 [Member] \| Due to Non-Redeeming Stockholders Current [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities	$ 151,189

FAIR VALUE MEASUREMENTS - Changes in the fair value of Level 3 liability (Details) - Due to Non-Redeeming Stockholders Current [Member]	9 Months Ended
	Sep. 30, 2023 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of December 31, 2022
Initial value	480,000
Payment to Non-redeeming Stockholders	(320,000)
Change in fair value of due to Non-redeeming Stockholders	(8,811)
Fair value as of June 30, 2023	$ 151,189

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Interest earned on the Trust Account		$ 1,328,243
Amount withdrawn for redemption of shares		$ 93,010,772
Asset transfer, into level 3	$ 0
Asset transfer, out of level 3	1
Liabilities transfer, into level 3	2
Liabilities transfer, out of level 3	$ 3
Due to Non-Redeeming Stockholders Current [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Sale of stock (per share)	$ 0.04	$ 0.04
US Mutual Funds [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
U.S. Mutual Funds Held in Trust Account	$ 26,711,906	$ 26,711,906	$ 118,377,460

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]	Nov. 08, 2023 Integer	Nov. 06, 2023 USD ($)	Oct. 11, 2023 USD ($)	Oct. 10, 2023 USD ($)	Oct. 03, 2023 USD ($)	Oct. 02, 2023 USD ($)
Subsequent Event [Line Items]
Amount paid to non-redeemable stockholders related to extension of combination		$ 240,000				$ 240,000
Drew additional amounts			$ 149,859	$ 149,859	$ 149,859	$ 149,859
Second Extension Amendment [Member]
Subsequent Event [Line Items]
Number of times up to which the business combination is consummated \| Integer	12
Period of extension amendment allowed	1 month